These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24123427)

  • 1. Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis.
    Nilsson H; Blomqvist L; Douglas L; Nordell A; Jacobsson H; Hagen K; Bergquist A; Jonas E
    J Magn Reson Imaging; 2014 Apr; 39(4):879-86. PubMed ID: 24123427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.
    Ringe KI; Hinrichs J; Merkle EM; Weismüller TJ; Wacker F; Meyer BC
    J Magn Reson Imaging; 2014 Jul; 40(1):106-12. PubMed ID: 24923477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI.
    Nilsson H; Nordell A; Vargas R; Douglas L; Jonas E; Blomqvist L
    J Magn Reson Imaging; 2009 Jun; 29(6):1323-31. PubMed ID: 19472389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.
    Nilsson H; Blomqvist L; Douglas L; Nordell A; Jonas E
    HPB (Oxford); 2010 Oct; 12(8):567-76. PubMed ID: 20887325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC).
    Hinrichs H; Hinrichs JB; Gutberlet M; Lenzen H; Raatschen HJ; Wacker F; Ringe KI
    Eur Radiol; 2016 Apr; 26(4):1116-24. PubMed ID: 26205638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization.
    Feng ST; Wu L; Chan T; Cai H; Luo Y; Zheng K; Tang D; Li ZP
    J Magn Reson Imaging; 2014 May; 39(5):1254-8. PubMed ID: 24115466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of classification trees for the qualitative differentiation of focal liver lesions suspicious for metastasis in gadolinium-EOB-DTPA-enhanced liver MR imaging.
    Schelhorn J; Benndorf M; Dietzel M; Burmeister HP; Kaiser WA; Baltzer PA
    Rofo; 2012 Sep; 184(9):788-94. PubMed ID: 22618476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.
    Saito K; Ledsam J; Sourbron S; Otaka J; Araki Y; Akata S; Tokuuye K
    J Magn Reson Imaging; 2013 May; 37(5):1109-14. PubMed ID: 23086736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.
    Nilsson H; Blomqvist L; Douglas L; Nordell A; Janczewska I; Näslund E; Jonas E
    Br J Radiol; 2013 Jun; 86(1026):20120653. PubMed ID: 23403453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N; Okada M; Murakami T
    Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image quality of Gd-EOB-DTPA-enhanced magnetic resonance imaging of the liver using dual-source parallel radiofrequency transmission technology: Comparison with the post-processing correction method for B1 inhomogeneity-induced signal loss.
    Takayama Y; Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Yoshiura T; Obara M; Hirakawa M; Honda H
    Eur J Radiol; 2012 Nov; 81(11):3035-40. PubMed ID: 22578836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-focused mutual information for nonrigid multimodal registration of liver CT and Gd-EOB-DTPA-enhanced MRI.
    Fernandez-de-Manuel L; Wollny G; Kybic J; Jimenez-Carretero D; Tellado JM; Ramon E; Desco M; Santos A; Pascau J; Ledesma-Carbayo MJ
    Med Image Anal; 2014 Jan; 18(1):22-35. PubMed ID: 24080528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.